-
Something wrong with this record ?
Protective factors against oxidative stress in COPD: focus on Nrf2-dependent antioxidant gene expression
E. Kominkova, M. Petrek, Z. Navratilova
Status not-indexed Language English Country Switzerland
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2014
Free Medical Journals
from 2014
PubMed Central
from 2014
Europe PubMed Central
from 2014
Open Access Digital Library
from 2014-01-01
Open Access Digital Library
from 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2014
- Publication type
- Journal Article MeSH
- Review MeSH
Chronic obstructive pulmonary disease (COPD) continues to be the world's primary cause of morbidity and mortality. The main mechanism driving the pathogenesis of COPD is oxidative stress. Antioxidant genes, regulated by the Nrf2/ARE signaling pathway, play a protective role against oxidative stress. Unfortunately, this pathway appears to be dysregulated in COPD, leading to decreased expression of antioxidant genes and persistent oxidative stress. We reviewed numerous studies measuring the expression of antioxidant genes in COPD. We also focused on developments in methods used to study gene expression in COPD over time, along with measuring antioxidant gene expression in various cell types, and the potential use of antioxidant gene expression as a predictor of COPD progression. And last but not least we discussed the association of cigarette smoke exposure with antioxidant gene expression together with antioxidant treatment in COPD. Understanding the altered expression of antioxidant genes in COPD could help in treating COPD, as well as predicting its progression.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25014434
- 003
- CZ-PrNML
- 005
- 20250905141347.0
- 007
- ta
- 008
- 250701e20250502sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmed.2025.1492256 $2 doi
- 035 __
- $a (PubMed)40385585
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kominkova, Eva $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 245 10
- $a Protective factors against oxidative stress in COPD: focus on Nrf2-dependent antioxidant gene expression / $c E. Kominkova, M. Petrek, Z. Navratilova
- 520 9_
- $a Chronic obstructive pulmonary disease (COPD) continues to be the world's primary cause of morbidity and mortality. The main mechanism driving the pathogenesis of COPD is oxidative stress. Antioxidant genes, regulated by the Nrf2/ARE signaling pathway, play a protective role against oxidative stress. Unfortunately, this pathway appears to be dysregulated in COPD, leading to decreased expression of antioxidant genes and persistent oxidative stress. We reviewed numerous studies measuring the expression of antioxidant genes in COPD. We also focused on developments in methods used to study gene expression in COPD over time, along with measuring antioxidant gene expression in various cell types, and the potential use of antioxidant gene expression as a predictor of COPD progression. And last but not least we discussed the association of cigarette smoke exposure with antioxidant gene expression together with antioxidant treatment in COPD. Understanding the altered expression of antioxidant genes in COPD could help in treating COPD, as well as predicting its progression.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Petrek, Martin $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 700 1_
- $a Navratilova, Zdenka $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 773 0_
- $w MED00188756 $t Frontiers in medicine $x 2296-858X $g Roč. 12 (20250502), s. 1492256
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40385585 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250701 $b ABA008
- 991 __
- $a 20250905141334 $b ABA008
- 999 __
- $a ok $b bmc $g 2388082 $s 1251554
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 12 $c - $d 1492256 $e 20250502 $i 2296-858X $m Frontiers in medicine $n Front Med (Lausanne) $x MED00188756
- LZP __
- $a Pubmed-20250701